psoriasis/potassium

It has been recognised that the sweat (extracellular area) excreted from those affected with psoriasis contains twice the amount of sodium and four times the amount of potassium in comparison to those not affected with psoriasis. According to Saalmann, after HUV therapy (SUP) there is a significant

OBJECTIVE To examine the reasons for resistance to treatment in cases of palmoplantar psoriasis, and also to compare the frequency of delayed-type hypersensitivity to common sensitizers with those cases of psoriasis without palmoplantar involvement. METHODS One hundred and three patients with

ShK is a 35-residue disulfide-linked polypeptide produced by the sea anemone Stichodactyla helianthus, which blocks the potassium channels Kv1.1 and Kv1.3 with pM affinity. An analogue of ShK has been developed that blocks Kv1.3 > 100 times more potently than Kv1.1, and has completed Phase 1b

BACKGROUND The use of potassium iodide (KI) to treat palmoplantar pustulosis (PPP) and pustulotic arthro-osteitis (PAO) has not previously been reported. Here, we report the first successful treatment of PPP and PAO with KI. METHODS Among 25 patients with PPP, seven had an associated PAO. All